FDA introduces ‘Elsa,’ a genAI tool to drive efficiency
The technology, which has been deployed ahead of schedule after an “aggressive timeline to scale AI agency-wide” is meant to boost productivity for clinical protocol reviews, scientific evaluations and more.
The technology, which has been deployed ahead of schedule after an “aggressive timeline to scale AI agency-wide” is meant to boost productivity for clinical protocol reviews, scientific evaluations and more.
Go to Source
2025-06-03 20:41
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.
